HIGHLIGHTS
- who: Jean-François Rossi from the Department of Hematology, University Hospital, CHU Saint Eloi, Augustin Fliche, Montpellier , France have published the research work: Targeted Therapies in Adult B-Cell Malignancies, in the Journal: (JOURNAL) of 13/03/2015
- how: This review discussed the principal aspects of such evident bioclinical progress. The first observations were made in patients treated for Rheumatoid Arthritis (RA) who experienced reduction of immune_response to vaccination and reactivation of viral infections not only hepatitis also observed in the context of B-CM but also progressive multifocal leukoencephalopathy (PML) a lethal encephalitis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.